| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 05/25/2006 | US20060110379 Linkage of agents using microparticles |
| 05/24/2006 | EP1465577A4 Methods for improving the aesthetic appearance of skin |
| 05/24/2006 | EP1039887B1 Use of aminothiol compounds for the treatment of neuro- and nephro-disorders and therapeutic toxicities |
| 05/23/2006 | US7049455 Process for producing shogaols and intermediates for the synthesis thereof |
| 05/23/2006 | US7049411 Human anti-factor IX/IXa antibodies |
| 05/23/2006 | US7048943 Carotenoid-loaded liposomes |
| 05/18/2006 | US20060106116 Composition for lessening oxidative stress |
| 05/18/2006 | US20060106108 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 05/18/2006 | US20060105990 Uronic acid-terminated carbohydrate having a double bond between the C4 and C5 atom of the uronic acid a maximum degree of polymerization of 100, combined with a mixture of two different undigestable prebiotic carbohydrates; blocking the adhesion of pathogens or toxins to eucariotic cells |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/17/2006 | EP1656155A2 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 05/17/2006 | EP1349864B1 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 05/17/2006 | EP1135411B1 Methods and compositions for treating disorders involving excitotoxicity |
| 05/17/2006 | CN1772181A Face nursing and life prolonging capsule and its prepn |
| 05/17/2006 | CN1256084C Applicaton of medicine for garlic oil anti radiation aleucocytosis reduction and DNA injury |
| 05/16/2006 | US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | CA2192535C 2-naphtamides derivatives and therapeutic uses thereof |
| 05/11/2006 | WO2006048430A1 SALTS OF N-ACYL-L-ASPARTATE-β-MONOESTER AND/OR OF N-ACYL-L-GLUTAMATE-Ϝ-MONOESTER, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN THERAPEUTIC OR COSMETIC COMPOSITIONS |
| 05/11/2006 | WO2005089731A3 Use of renin inhibitors in therapy |
| 05/11/2006 | US20060100258 Growth promotion method |
| 05/10/2006 | EP1655281A1 Salts of N-acyl-L-aspartate-beta-mono-ester and/or of N-acyl-L-glutamate-gamma-monoester, the process for preparing them and their use in therapeutic or cosmetic compositions |
| 05/10/2006 | EP1653948A2 Use of 5-methoxytryptamine as a cardioprotective agent |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | CN1768838A Chinese medicine preparation for promoting lead-removal and its preparation process |
| 05/10/2006 | CN1768795A Hawthorn fruit physiological activity |
| 05/10/2006 | CN1768778A Application of cassia seed in preparation of lead-remove promoting drug or health-caring product |
| 05/10/2006 | CN1768766A Compound saline algae capsule |
| 05/10/2006 | CN1768746A Novel medical use of matrine alkaloid |
| 05/10/2006 | CN1255167C Anti-oxidation health care nutrient oil |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041652 administering ascorbic acid, ascorbate or a derivative thereof in combination with quercetin-3-O-glucoside (isoquercetin), quercetin-4'-glucoside, quercetin-3'-glucoside, or quercetin-7-glucoside to increase bioavailability |
| 05/09/2006 | US7041322 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 05/09/2006 | US7041321 supercritically extracting an herb to obtain an oil extract and a residue;extracting the residue in a water/alcohol liquid mixture to obtain a post-supercritical hydroalcoholic extract; evaporating the water/alcohol liquid to form a powdered extract; mixing the powdered extract with the oil extract. |
| 05/04/2006 | WO2006046257A2 An ayurvedic composition and process for preparing the composition to act as anti snake-venom |
| 05/03/2006 | EP1652519A1 Seleniferous composition for producing antioxidase in vivo |
| 05/03/2006 | CN1765912A Pyracantha extract and its preparation method and uses |
| 05/02/2006 | US7037533 Functional agent for decomposing nicotine and method of preparing the same |
| 04/27/2006 | WO2006045050A1 Methods and compositions for protecting cells from ultrasound-mediated cytolysis |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006042479A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/27/2006 | US20060089313 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | CA2584299A1 Methods and compositions for protecting cells from ultrasound-mediated cytolysis |
| 04/27/2006 | CA2574518A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/26/2006 | EP1650206A1 Phenylazole compounds, production process, and antioxidants |
| 04/26/2006 | EP1492524B1 Vitamin combination for providing protection during the chemotherapy and/or radiotherapy of malignant tumours |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1762457A Anti-fatigue anti-senility, sexual function improving Chinese medicinal composition and its preparation method |
| 04/26/2006 | CN1762399A American ginseng effervescence tablet and its preparation method |
| 04/26/2006 | CN1762386A Bone density-increasing and senility-postponing capsule formulation |
| 04/26/2006 | CN1762380A Nano selenium product and its preparation method |
| 04/26/2006 | CN1762365A Beta-carotene clathrate and its preparation method |
| 04/26/2006 | CN1253451C Novel indodyl oxazole compound and its preparation and application |
| 04/25/2006 | US7033606 Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis |
| 04/25/2006 | CA2438097C Cannabinoids pharmaceutical formulations |
| 04/20/2006 | US20060084626 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/20/2006 | US20060083686 Therapeutic agent for ulcerative colitis |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1227820B1 Oligosaccharide aldonic acids and their topical use |
| 04/19/2006 | EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions |
| 04/19/2006 | EP1080726B1 Agents for relieving side effects |
| 04/19/2006 | EP0930877B1 D-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 04/19/2006 | CN1761452A Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 04/19/2006 | CN1760172A Tetra-(alpha-amino-acid or dipeptide) complexes of di-copper and synthetic method, and SOD loke activity |
| 04/19/2006 | CN1251613C Health care food for anti-oxidation and immunoregulation and its making method |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 04/18/2006 | US7030087 A water-soluble polypeptide having hydrophobic side chains, for use as bactericides treating infections, detoxification of endotoxin, cell antiproliferative agents, antagonist of tumor necrosis factor |
| 04/18/2006 | US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 04/13/2006 | WO2006038690A1 Functional food and drink |
| 04/13/2006 | WO2006037224A1 Isolated clk-1 -i- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders |
| 04/13/2006 | US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 04/13/2006 | US20060078551 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python |
| 04/13/2006 | DE10320633B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1404174A4 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/12/2006 | EP1355639B1 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/12/2006 | EP1317272B1 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1233767B1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2006 | EP0861319B1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 04/12/2006 | EP0843726B1 Opioid antagonists and methods of their use |
| 04/12/2006 | CN1758913A Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 04/12/2006 | CN1757409A Recipe of Wanshou capsule, and health-care function |
| 04/12/2006 | CN1757397A Biological deodorization method for dried oviduct fat of forest frog |
| 04/12/2006 | CN1250528C Cyclic nitrones and pharmaceutical compositions containing them |
| 04/12/2006 | CN1250246C Medicinal mixture possessing alpha glycocidase inhibiting activity and its use |
| 04/12/2006 | CN1250232C Lactic acid bacteria and bifidobacteria, composition containing them and its use |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026361 Dispersion stability; forming protective colloid; bioavailability; hypotensive agents, oral diseases |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026140 Serum paraoxonase |
| 04/11/2006 | US7026005 Dehydrating; steaming; drying; freezing; pulverization |
| 04/06/2006 | WO2006035900A1 Coenzyme q10-containing emulsified composition |
| 04/06/2006 | WO2006035142A1 Preparation of phenol-amide compounds with antioxidant properties |
| 04/06/2006 | US20060074062 Substituted porphyrins |